Orem, UT, April 22, 2007 --(PR.com
)-- ZYTO Corp. (OTC - ZYTC.pk) announced today that it will hold its annual meeting of stockholders on May 5, 2007 at 5 p.m. at the Zermatt Resort and Spa, 784 West Resort Drive, Midway, UT 84049.
Stockholders of record at the close of business on April 18, 2007 are entitled to vote at the annual meeting. All shareholders are invited to attend in person.
The purpose of the meeting is to elect five directors of the company, and to transact such other business as may properly come before the meeting. The following five individuals were nominated for election:
Dr. Vaughn R Cook, OMD, president/CEO of ZYTO Corp. and founder of the company.
Dr. Dennis A. Robbins, Ph.D., MPH, served as an advisor to the President’s Commission on Ethical Issues in Biomedicine, Biomedical and Behavioral Research.
Dr. Marc Leib, M.D., J.D., is a prominent attorney and physician with significant experience dealing with the Health Insurance Portability and Accountability Act (HIPAA), health care antitrust matters, and Food and Drug Administration oversight of medical devices.
Goodwin Wang, established SES Investment (China), based in Shanghai, and has assisted Fortune 500 companies successfully launching into China.
Duane Davis, vice president of sales for ZYTO Corp., has worked in the alternative medical field for many years, and spent extensive time teaching and educating healthcare practitioners in the use and success of energy technologies.
A detailed invitation with a biographical sketch of each nominee has been mailed to stockholders of record, and is available through the company web site at http://www.ZYTO.com
About ZYTO Corp.
ZYTO Corp. was founded by Dr. Vaughn Cook, OMD. The company provides computerized bio-technology equipment and software with clinical applications that include obtaining information from the human body to assist healthcare practitioners to make better decisions.
Forward Looking Statement:
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports the Company may file.
Dr. Vaughn Cook